与尼沃卢马布相关的自身免疫脑炎,其次是瘤回归
Shirly J Mysler1, Florencia Perazzo2, Pablo Mandó2
1Departamento de Oncología, Hospital CEMIC, Buenos Aires, Argentina. E-mail:
Medicina
|June 28, 2023
概括
免疫检查点抑制剂可以在细胞癌患者中引起严重的自身免疫脑炎. 及时的皮质类固醇治疗导致完全康复和持续的癌症反应,即使在停止免疫治疗后.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 神经学 神经学
背景情况:
- 免疫检查点抑制剂 (ICI) 改善了IV期细胞癌 (RCC) 的存活率.
- 免疫相关不良事件 (IRAE),包括自身免疫性脑炎 (AE),是ICI的重大并发症.
- 最佳管理ICI诱导的AE和随后的抗瘤反应仍然不清楚.
研究的目的:
- 在接受尼沃卢马布治疗的第四阶段RCC患者中报告自身免疫脑炎病例.
- 讨论这种严重的中枢神经系统IRAE的临床管理.
- 为了评估AE治疗和免疫治疗停止后的瘤疾病反应.
主要方法:
- 一个67岁的女性患有IV期RCC的病例报告,该病例在nivolumab.
- 用高剂量的皮质类固醇治疗自身免疫性脑炎.
- 监测神经恢复和瘤疾病状态.
主要成果:
- 患者在nivolumab治疗期间发生了自身免疫性脑炎.
- 神经症状在高剂量皮质类固醇治疗5天内显著改善.
- 尽管停止了尼沃卢马布治疗,但患者仍取得了持续的抗瘤反应.
结论:
- 自身免疫性脑炎是一种罕见但严重的IRAE,与RCC中的ICI相关.
- 高剂量的皮质类固醇在治疗ICI诱导的自身免疫性脑炎方面是有效的.
- 由于IRAE而停止ICI可能不一定会影响长期抗瘤疗效.
相关概念视频
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Autoimmune Disorders
526
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
526
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


